- 期刊
原發性抗磷脂質症候群病人在中風病程的抗凝血治療：病例報告
Anticoagularnt Therapy in Primary Antiphospholipid Syndrome Patient after Cerebrovascular Accident : A Case Report
摘要
原發性抗磷脂質症候群(primary antiphospholipid syndrome)是少見的血管病變，一般出現在幼童或年輕型中風的病人，本文報告一位31歲女性患者，原先就有多次流產的病史，直到中風發作後才被診斷為原發性抗磷脂質症候群，然後開始抗凝血治療及適當復健，而經過1年10個月追蹤觀察沒有復發血管病變，希望藉由報告此病例，建議在面對多次流產的年輕病人時，應該將抗磷脂質症候群列為重要的鑑別診斷。
並列摘要
Primary antiphospholipid syndrome is a rare disease of vasculopathy, which is usually found in the stroke partient with onset during childhood and young adulthood. We report a female patient who had a history of multiple spontaneous abortions in the past. However, the diagnosis was not made until a cerebrovascular accident happened to her. After then, she started to receive anticoagulant therapy and rehabilitation program. No further cerebrovascular accident occurred in the following 22 months. By this report, we remind that a female patient with history of frequent abortion needs to be investigated carefully to search the possibility of antiphospholipid syndrome.
延伸閱讀
- 林雅如、黃英庭、崔百青、蔡力凱、鍾芷萍、郭書帆、宋碧姍、傅維仁、心房纖維顫動預防中風治療指引共識小組（2019）。2019台灣腦中風學會非維他命K拮抗劑口服抗凝血劑用於心房纖維顫動患者中風預防治療指引。台灣中風醫誌，1(3)，143-184。https://doi.org/10.6318/FJS.201912_1(3).0001
- 翁文章（2006）。低劑量抗凝血使用於急性缺血性中風的時機與安全性評估。腦中風會訊，13(1)，10-11。https://doi.org/10.6318/STROKE.200601_13(1).0004
- 李怡慧（2022）。第XI因子抑制劑：新抗凝劑在急性缺血性腦中風的效益。台灣中風醫誌，4(4)，207-211。https://doi.org/10.6318/FJS.202212_4(4).0002
- Hsu, Y. C., & Lin, S. C. (2010). Thrombolytic Therapy Improves a Patient with Massive Pulmonary Embolism and Unstable Hemodynamics: A Case Report. 重症醫學雜誌, 11(2), 134-139. https://doi.org/10.30035/TCCM.201008.0009
- Chen, Y. C., Chao, Y. L., & Tung, C. L. (2017). A Case Report of Anti-N-methyl-D-aspartate Receptor Encephalitis Comorbid with Neuroleptic Malignant Syndrome. 臺灣精神醫學, 31(2), 180-182. https://www.airitilibrary.com/Article/Detail?DocID=10283684-201706-201707040025-201707040025-180-182